Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Science 37 Holdings Inc SNCE

Financial Services Technology Scientific & Technical Instruments
Science 37 Holdings, Inc. is engaged in patient-centric clinical trials and in supporting novel approaches to decentralized clinical trial designs. Through its patient-centric approach, it reduces the impact of the geographic barriers associated with conventional physical clinical trial sites, enabling recruitment of virtually any patient. Its offerings lie in its configurable unified... see more

Recent & Breaking News (NDAQ:SNCE)

Science 37 to Report First Quarter 2022 Financial Results on May 9, 2022

GlobeNewswire April 25, 2022

Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic Depth

GlobeNewswire March 31, 2022

Science 37 Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire March 22, 2022

Science 37 to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022

GlobeNewswire March 8, 2022

New Science 37® CNS Survey Confirms Growing Trend in Clinical Trials Landscape

GlobeNewswire March 1, 2022

Science 37®'s Operating System Receives ISO Certification for Information Security Management

GlobeNewswire February 24, 2022

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

GlobeNewswire February 23, 2022

Science 37®'s Community Provider Network Grows Sixfold, Reaching Nearly 28 Million Patients

GlobeNewswire February 17, 2022

Science 37® and physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

GlobeNewswire February 3, 2022

Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials(TM) and Accelerate Study Timelines

GlobeNewswire January 18, 2022

Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development

GlobeNewswire December 7, 2021

Science 37® Reveals a Pivotal Shift in the Clinical Trials Landscape

GlobeNewswire November 17, 2021

Science 37 Reports Quarterly Financial Results for the Period Ended September 30, 2021

GlobeNewswire November 15, 2021

Science 37 to Report Third Quarter 2021 Financial Results on November 15, 2021

GlobeNewswire November 1, 2021

Science 37® and CMIC Announce Partnership to Advance Decentralized Clinical Trials in Japan/APAC and Speed Drug Development

GlobeNewswire October 27, 2021

Science 37® and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment

GlobeNewswire October 27, 2021

Industry-veteran Elisa Cascade Joins Science 37 as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer

GlobeNewswire October 13, 2021

Emily Rollins Appointed to Science 37® Board of Directors

GlobeNewswire October 12, 2021

Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE

GlobeNewswire October 7, 2021

LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination

GlobeNewswire June 16, 2021